These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2487531)

  • 21. Clinical experience with sotalol in patients with drug-refractory ventricular arrhythmias.
    Ruder MA; Ellis T; Lebsack C; Mead RH; Smith NA; Winkle RA
    J Am Coll Cardiol; 1989 Jan; 13(1):145-52. PubMed ID: 2909562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiarrhythmic effects of indecainide in a drug-resistant population with ventricular tachycardia at programmed electrical stimulation.
    Miura DS; Wynn J; Keefe D; Laux B; Somberg JC
    Am Heart J; 1987 Jan; 113(1):65-9. PubMed ID: 3799443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electrophysiologic effects of intravenous and oral sotalol for sustained ventricular tachycardia secondary to coronary artery disease.
    Kopelman HA; Woosley RL; Lee JT; Roden DM; Echt DS
    Am J Cardiol; 1988 May; 61(13):1006-11. PubMed ID: 3284316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative efficacy of oral sotalol and procainamide in patients with chronic ventricular arrhythmias: a multicenter study.
    Lidell C; Rehnqvist N; Sjögren A; Yli-Uotila RJ; Rønnevik PK
    Am Heart J; 1985 May; 109(5 Pt 1):970-5. PubMed ID: 3887877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and electrophysiologic effects of oral sotalol in patients with sustained ventricular tachycardia caused by coronary artery disease.
    Kus T; Campa MA; Nadeau R; Dubuc M; Kaltenbrunner W; Shenasa M
    Am Heart J; 1992 Jan; 123(1):82-9. PubMed ID: 1729853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The response to procainamide during electrophysiologic study for sustained ventricular tachyarrhythmias predicts the response to other medications.
    Waxman HL; Buxton AE; Sadowski LM; Josephson ME
    Circulation; 1983 Jan; 67(1):30-7. PubMed ID: 6847803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The efficacy, electrophysiologic and electrocardiographic effects of intravenous pirmenol, a new class I antiarrhythmic agent, in patients with ventricular tachycardia: comparison with procainamide.
    Gold RL; Frumin H; Haffajee CI; Kerin NZ; Jarandilla R
    Pacing Clin Electrophysiol; 1988 Mar; 11(3):308-14. PubMed ID: 2452418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Usefulness of sotalol for life-threatening ventricular arrhythmias.
    Roden DM
    Am J Cardiol; 1993 Aug; 72(4):51A-55A. PubMed ID: 8346727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Response to sotalol predicts the response to amiodarone during serial drug testing in patients with sustained ventricular tachycardia and coronary artery disease.
    Martínez-Rubio A; Shenasa M; Chen X; Wichter T; Breithardt G; Borggrefe M
    Am J Cardiol; 1994 Feb; 73(5):357-60. PubMed ID: 7509121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paired comparisons of efficacy of intravenous and oral procainamide in patients with inducible sustained ventricular tachyarrhythmias.
    Interian A; Zaman L; Velez-Robinson E; Kozlovskis P; Castellanos A; Myerburg RJ
    J Am Coll Cardiol; 1991 Jun; 17(7):1581-6. PubMed ID: 2033190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of procainamide on induced ventricular tachycardia.
    Engel TR; del Gonzalez A; Meister SG; Franki WS
    Clin Pharmacol Ther; 1978 Sep; 24(3):274-82. PubMed ID: 688720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A multicentre, double-blind randomized crossover comparative study on the efficacy and safety of dofetilide vs sotalol in patients with inducible sustained ventricular tachycardia and ischaemic heart disease.
    Boriani G; Lubinski A; Capucci A; Niederle R; Kornacewicz-Jack Z; Wnuk-Wojnar AM; Borggrefe M; Brachmann J; Biffi M; Butrous GS;
    Eur Heart J; 2001 Dec; 22(23):2180-91. PubMed ID: 11913480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative efficacy of pirmenol and procainamide in a drug-resistant population with ventricular tachycardia.
    Miura DS; Schwartz J; Laux B; Wynn J; Keefe D; Somberg JC
    J Clin Pharmacol; 1987 Jul; 27(7):481-6. PubMed ID: 3654999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sotalol in patients with life-threatening ventricular tachyarrhythmias.
    Trappe HJ; Klein H; Lichtlen P
    Cardiovasc Drugs Ther; 1990 Oct; 4(5):1425-32. PubMed ID: 2278875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrophysiologic and clinical factors influencing response to class IA antiarrhythmic agents in patients with inducible sustained monomorphic ventricular tachycardia.
    Gold RL; Haffajee CI; Alpert JS
    Am Heart J; 1986 Jul; 112(1):9-13. PubMed ID: 3728294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term efficacy of d/l sotalol in patients with sustained ventricular tachycardia refractory to class I antiarrhythmic drugs.
    Kühlkamp V; Mermi J; Mewis C; Braun U; Seipel L
    Eur Heart J; 1995 Nov; 16(11):1625-31. PubMed ID: 8881857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of procainamide and lidocaine on electrically inducible ventricular tachycardia studied with programmed ventricular stimulation in post myocardial infarction.
    Iesaka Y; Aonuma K; Nitta J; Tokunaga T; Fujiwara H; Hiraoka M
    Jpn Circ J; 1988 Mar; 52(3):262-71. PubMed ID: 3373718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized crossover comparison of the electrophysiologic and antiarrhythmic efficacy of oral cibenzoline and sotalol for sustained ventricular tachycardia.
    Hoffmann E; Mattke S; Haberl R; Steinbeck G
    J Cardiovasc Pharmacol; 1993 Jan; 21(1):95-100. PubMed ID: 7678686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid intravenous infusion of d-1 sotalol: time to onset of effects on ventricular refractoriness, and safety.
    Ho DS; Zecchin RP; Cooper MJ; Richards DA; Uther JB; Ross DL
    Eur Heart J; 1995 Jan; 16(1):81-6. PubMed ID: 7737227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative mechanisms of antiarrhythmic drug action in experimental atrial fibrillation. Importance of use-dependent effects on refractoriness.
    Wang J; Bourne GW; Wang Z; Villemaire C; Talajic M; Nattel S
    Circulation; 1993 Sep; 88(3):1030-44. PubMed ID: 8353865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.